Drug for coeliac disease may help treat severe post-Covid syndrome in children
Covid infection, although rare in kids, leads to multisystem inflammatory syndrome in children (MIS-C) -- a serious condition that presents as high fevers, gastrointestinal symptoms, and life-threatening cardiac injury.
The trial results, published in the journal Science Translational Medicine, showed that larazotide supported children in returning to normal activities more rapidly following Covid.
"While our study is small, its results are powerful and have implications not only for MIS-C, but potentially for long Covid," said lead author Lael Yonker, co-director of the Cystic Fibrosis Center, at Mass General Brigham.
"Our findings suggest that larazotide is safe and quickly resolves symptoms in children with MIS-C. We are now running a clinical trial to test whether larazotide may also be a useful therapy to treat patients with long Covid," Yonker added.
Current MIS-C treatments are limited. Some patients receive general anti-inflammatory drugs, but many experience a rebound of symptoms after completing a course. Such drugs are not designed to target the sticky SARS-CoV-2 viral particles that may persist in the gut.
On the other hand is the orally administered Larazotide, which targets the gut and strengthens intestinal barriers to limit the number of materials -- like SARS-CoV-2 viral particles -- that exit the intestines and enter circulation.
To test larazotide's efficacy and safety as an MIS-C treatment, researchers conducted a double-blind clinical trial with 12 children experiencing early-stage MIS-C.
Each patient randomly received either a placebo or larazotide four times daily for 21 days, then was tracked over six months of recovery.
Children who received larazotide showed faster resolution of gastrointestinal symptoms, faster clearance of SARS-CoV-2 viral particles, and more rapid return to normal activities, the team said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
27 minutes ago
- Indian Express
Chinese students at UK universities asked to monitor classmates, report on talks critical of China: report
Chinese students in the UK are being asked by officials to monitor their classmates and report on discussions that may be critical of China, according to a new report by the UK-China Transparency (UKCT) think tank, the BBC reports. The report, based on a survey of academics in China studies, also found that some university staff had been warned by Chinese officials not to speak about certain topics in class. The Chinese embassy in London rejected the findings, telling the BBC the report was 'groundless and absurd'. A spokesperson said China respects freedom of speech in the UK and does not interfere in the internal affairs of other countries. The findings come soon after a new law came into effect in the UK, requiring universities to actively promote academic freedom and free speech, even when they have partnerships with foreign governments. The Office for Students (OfS), the higher education regulator, said freedom of speech and academic freedom are 'fundamental' to universities. OfS chief executive Susan Lapworth has said Confucius Institutes—cultural centres funded by the Chinese government and hosted at UK universities—should be examined under the new law due to concerns about foreign influence. Some universities may hesitate to raise concerns about interference because of the high number of Chinese students and the fees they pay, the UKCT said. According to the report, some students from China told lecturers they had been asked by officials to observe and report on their peers. Other students said they felt uncomfortable discussing topics considered sensitive by the Chinese government, and were reluctant to pursue further study in those areas. Topics seen as sensitive include China's policies in Xinjiang, the origins of Covid-19, and the country's growing tech industry. Some academics also said they had been harassed or intimidated. The report said some researchers were denied visas to China, and others said their families in China were pressured because of their work in the UK. There were also reports of intimidation by visiting Chinese scholars and by staff linked to Confucius Institutes. The OfS said it already has powers to ensure universities protect free speech, including from foreign influence. These powers will be expanded to include a new complaints system where staff and visiting speakers can raise concerns directly with the regulator. Universities that fail to protect academic freedom could face fines, with one already being fined £585,000 earlier this year. Universities UK, a group representing 141 institutions, said: 'Any threats to the freedom of our staff or students are taken very seriously. We work closely with the government to prevent this.' A government spokesperson said, 'Anyone working or studying at our universities should know their rights to personal and academic freedom are protected when they are on British soil.' Skills Minister Jacqui Smith added, 'Academic freedom is non-negotiable in our universities. Any attempt by a foreign state to intimidate or harass people in the UK will not be tolerated.' She said the new law makes universities' responsibilities clear, and that institutions failing to act 'will face the consequences'. (With inputs from BBC)
Hindustan Times
an hour ago
- Hindustan Times
A Turning Point in Colon Cancer: Young People Are Finding It Earlier
People under age 50 have been appearing increasingly at doctor's offices in the past few decades, complaining of blood in their stool or bowel or of abdominal trouble or unexplained weight loss. The diagnosis: colorectal cancer . And by that time, it was often too late. But that paradigm is finally starting to shift, at least for patients in their 40s. There has been a jump in people aged 45 to 49 getting screened for colorectal cancer, after recent medical guidelines lowered the screening age for those at average risk. As a result, the disease is being caught sooner, when it is more curable and the treatment is less grueling, according to new research from the American Cancer Society. The recent screening recommendations designed to catch cases sooner appear to be working. 'It's thrilling to see this,' said Rebecca Siegel, an epidemiologist at the ACS and an author of the new research. 'It means fewer deaths and higher quality of life for people who are diagnosed.' The findings come in a flurry of research published Monday in the Journal of the American Medical Association. Colorectal cancer screening in the U.S. for adults age 45 to 49 increased by 62% from 2019 to 2023, according to one ACS paper. Early-stage diagnoses then surged, including a 50% relative increase from 2021 to 2022, according to another ACS report. A trial of more than 20,000 people in the same age bracket was published by a separate group of researchers, showing that testing uptake increases when people are mailed stool tests by default, versus when they are asked if they want a test or a colonoscopy. Screening rates in the trial were low, however, with 19% of people in the trial overall opting to get screened. 'We probably shouldn't be wasting time asking patients first; we should send them what they need,' said Dr. Folasade May, the trial's senior author and a gastroenterologist at the University of California, Los Angeles. 'We have a long way to go.' Colorectal cancer rates have been rising for people under age 50 since the 1990s, and the disease is now the leading cause of cancer death among men in that group. Researchers are investigating everything from diet and lifestyle to environmental contaminants, to figure out why colorectal and other cancers are rising in younger adults. The ACS in 2018 started recommending that people with average risk as young as 45 years old get screened for colorectal cancer, down from the previous start of age 50. The U.S. Preventive Services Task Force followed in 2021; their guidelines carry particular weight among primary-care providers and often lead to health-insurance coverage. Suddenly, millions of people were newly overdue for screening. For people in that 45-to-49 age bracket, cases jumped, going from about a 1% increase in the incidence rate each year since 2004 to a 12% annual rise from 2019 to 2022, the data show. The rise was driven by diagnoses of early-stage disease. A post-Covid rebound in people seeking healthcare could contribute to some of the increase, researchers said, but the change in screening guidance is likely the bigger factor. The trend looks similar to what happened among people ages 50 and above in the late 1990s, after screening was first recommended for them, said Caitlin Murphy, a cancer epidemiologist and professor of pediatrics at the University of Chicago, who wasn't involved in the studies. It will still take time to see what the impact on deaths looks like for the newly eligible, she said. 'Ultimately, the goal of screening is to reduce mortality, and we haven't seen that quite yet, simply because not enough time has gone by.' Up-to-date screening via colonoscopy for those aged 45 to 49 rose from around 20% of people in 2019 to about 28% in 2023, according to one of the ACS reports. A colonoscopy is the gold-standard test that also helps doctors remove polyps to actually prevent the cancer from forming. Alternatively, use of tests that look for blood or DNA changes in the stool also increased, rising from 1.3% to 7.1% in that age group. Screening rates remained mostly stable in all other age groups, the report found. Screening rates also remained unchanged for people ages 45 to 49 with less than a high-school education or who are uninsured. And they still trail behind those for older adults, who remain at higher risk. Factors including genetics, excess body weight, smoking cigarettes and a diet heavy in red and processed meats also increase a person's odds of developing the disease. People in the 45-to-49 age bracket account for nearly half of all colorectal cancers under age 50, ACS said. But that still leaves a lot of people who are at risk and are too young to be screened. 'I have patients in their 20s in my practice that would never fit the guidelines,' said Dr. Michael Cecchini, a medical oncologist and colorectal cancer specialist at Yale Cancer Center. 'We need to be thinking about it on our list of possible diagnoses.' Write to Brianna Abbott at
Time of India
4 hours ago
- Time of India
Doctors fight vaccine mistrust as Romania hit by measles outbreak
Răuceşti: When epidemiologist Daniela Gafita makes her rounds in the remote villages of northeastern Romania to educate communities about the risks of measles, she frequently encounters parents who hesitate to have their children vaccinated. With measles cases in Europe hitting a 25-year high last year, Romania was the country most affected: it recorded 13,000 of the approximately 18,000 cases registered between June 2024 and May 2025 in the European Economic Area, which includes EU members as well as Iceland, Liechtenstein and Norway. But the disease has also re-emerged globally, with the United States confronting its worst epidemic in 30 years, in part fuelled by anti-vaccine misinformation that has been circulating on social media since the Covid-19 pandemic. Despite widespread vaccine scepticism in Romania, Gafita and her colleagues from the local health department are undeterred in their mission to spread the immunisation message. "We are trying to recover little by little what we lost" in the past decades when the situation was still at bay, said the 52-year-old. Romania has the EU's lowest vaccination rate at 62 percent, a far cry from the 95 percent the World Health Organization (WHO) says is needed for effective control. - Irrational fear - But it's a fight on many fronts, due not only to poverty but also poor access to health care and persistent rumours that vaccination causes autism. "I heard the vaccine is dangerous," said a woman, who declined to give her name, in the village of Raucesti. Elena Armenia, who also lives in the village of 7,500 people, told AFP that she did not want her youngest child to be vaccinated after reading "about a link to autism" online, a misconception that has been refuted by the scientific community. "Fear crept into my mind and I can't shake it off," said the 34-year-old. Her neighbours' children recently ended up in hospital after contracting measles, a contagious disease that causes fever, respiratory symptoms and a rash -- but can also lead to pneumonia, brain inflammation and even death. Romania reported eight fatalities from measles between June 2024 to May 2025. In July, a child died in Britain, with three deaths being recorded in the United States this year. Family doctor Monica Apostol told AFP that she was less optimistic than some of her colleagues about Romania's vaccination rate being boosted soon. "I'm hitting a brick wall," she said about her many conversations with parents. - Far-right anti-vaxers - Several factors have contributed to lower vaccination rates and subsequently to the resurgence of measles in Romania, where jabs are offered for free but are not mandatory. Millions of Romanians, including many health professionals, left the country after the end of communism in 1989. Moreover, the country has seen periods of vaccine shortages, but also an underfunded healthcare system and an increasing lack of trust in authorities. During the Covid pandemic, public figures in Romania but also worldwide began launching or endorsing anti-vaccination campaigns, with US President Donald Trump appointing Robert F. Kennedy Jr as health secretary despite his support of anti-vaccine conspiracy theories. Romania's far right also seized on anger over strict pandemic measures and started promoting anti-vaccine beliefs. Far-right leader George Simion, who topped the first round of the presidential election in May before losing in the second round, has said that parents should have the freedom to decide whether to have their children vaccinated or not. Pro-European President Nicusor Dan recently called on authorities to redouble their efforts to "regain people's trust", and combat a deluge of conspiracy theories and fake news that has eroded confidence. "The recent elections have shown that misinformation campaigns are conducted in a highly professional manner," said Gindrovel Dumitra, coordinator for vaccinations at one of Romania's main doctors' associations. Faced with a situation that is "out of control", his colleague Gafita advocates for tougher nationwide rules, including the need for children to be vaccinated to be able to attend school. "Even if such measures are unpopular and contrary to what many people want," she said.
